journal cover

Dual-Targeted Delivery of Nanoparticles Encapsulating Paclitaxel and Everolimus: a Novel Strategy to Overcome Breast Cancer Receptor Heterogeneity

Pharmaceutical Research

Jan 23, 2020

Loujin HoudaihedChristine Allen

Abstract

The intratumoral heterogeneity observed in breast cancer (BC), in particular with regard to cell surface receptor expression, can hinder the success of many targeted cancer therapies. The development of novel therapeutic agents that target more than one receptor can overcome this inhere...read more

Mentioned in this Paper

Three-dimensional
Fatty Acids, Monounsaturated
Polymers
Intratumoral
Therapeutic agent (substance)
Protein Expression
Receptor
Epidermal Growth Factor Receptor
Gene Mutant
Breast Cancer Cell
Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.

Similar Papers Found In These Feeds

Breast Cancer: Therapeutic Approaches

Several different therapeutic approaches are used to treat breast cancer. These include chemotherapy, hormonal therapy, targeted therapy, and Immunotherapy. Discover the latest research on breast cancer therapeutic approaches here.

Hormone-Related Cancers

This feed focuses on hormone-related cancers including cancer of the breast, endometrium, ovary, prostate, testis, thyroid, and bone, all of which share unique mechanisms of carcinogenesis. Here is the latest research.

© 2020 Meta ULC. All rights reserved

Dual-Targeted Delivery of Nanoparticles Encapsulating Paclitaxel and Everolimus: a Novel Strategy to Overcome Breast Cancer Receptor Heterogeneity

Pharmaceutical Research

Jan 23, 2020

Loujin HoudaihedChristine Allen

PMID: 31965330

DOI: 10.1007/s11095-019-2684-6

Abstract

The intratumoral heterogeneity observed in breast cancer (BC), in particular with regard to cell surface receptor expression, can hinder the success of many targeted cancer therapies. The development of novel therapeutic agents that target more than one receptor can overcome this inhere...read more

Mentioned in this Paper

Three-dimensional
Fatty Acids, Monounsaturated
Polymers
Intratumoral
Therapeutic agent (substance)
Protein Expression
Receptor
Epidermal Growth Factor Receptor
Gene Mutant
Breast Cancer Cell

Similar Papers Found In These Feeds

Breast Cancer: Therapeutic Approaches

Several different therapeutic approaches are used to treat breast cancer. These include chemotherapy, hormonal therapy, targeted therapy, and Immunotherapy. Discover the latest research on breast cancer therapeutic approaches here.

Hormone-Related Cancers

This feed focuses on hormone-related cancers including cancer of the breast, endometrium, ovary, prostate, testis, thyroid, and bone, all of which share unique mechanisms of carcinogenesis. Here is the latest research.

Related Papers

Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.
/papers/dual-targeted-delivery-of-nanoparticles/31965330